Clinical Trial Update: Amantadine Therapy for Cognitive Impairment in Long COVID [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating amantadine for cognitive impairment in Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute COVID-19 Syndrome
• Post-covid-19 Condition

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Ohio State University | Conditions: Long COVID, Post-COVID19 Condition | Phase 2 | Status: COMPLETED